Volume 10, Number 7—July 2004
Transporting Patient with Suspected SARS
Highlight and copy the desired format.
|EID||Tsai S, Tsang C, Wu H, Lu L, Pai Y, Olsen M, et al. Transporting Patient with Suspected SARS. Emerg Infect Dis. 2004;10(7):1325-1326. https://dx.doi.org/10.3201/eid1007.030608|
|AMA||Tsai S, Tsang C, Wu H, et al. Transporting Patient with Suspected SARS. Emerging Infectious Diseases. 2004;10(7):1325-1326. doi:10.3201/eid1007.030608.|
|APA||Tsai, S., Tsang, C., Wu, H., Lu, L., Pai, Y., Olsen, M....Chiu, W. (2004). Transporting Patient with Suspected SARS. Emerging Infectious Diseases, 10(7), 1325-1326. https://dx.doi.org/10.3201/eid1007.030608.|
To the Editor: The severe acute respiratory syndrome (SARS) outbreak in Taiwan can be traced back to a Taiwanese businessman returning from mainland China to Taiwan in March 2003 (1). In May 2003, several outer islands belonging to Taiwan reported SARS, and on June 2, 2003, Penghu Army Hospital reported a 40-year-old man with suspected SARS. The patient complained of shortness of breath and a dry cough. He had visited a person with confirmed SARS 7 days earlier. He had a temperature of 38.4°C and leukocyte count of 7,920 cells/μL, and his chest x-ray showed infiltration in both lower lobes.
Because medical facilities are limited on these islands, the Department of Health authorized the National Aeromedical Consultation Center (NACC), a physician-based 24-hour control center that coordinates all aeromedical transport of critically ill or injured patients within Taiwan, to coordinate transporting these patients to designated SARS hospitals in Taipei. The NACC dispatched an aircraft (Fokker 50) with a specialized team of two flight physicians, one flight paramedic, and a PIU (portable isolation unit) on board. During the flight, the medical crew prepared equipment and dressed themselves in three layers of personal protective equipment. On arrival at Penghu, only essential equipment was taken into the hospital. One physician entered the isolation room, taking the PIU with him. The rest of the crew and equipment remained in the pre-isolation room. The patient was briefed about the transport and given 10 mg of metoclopramide to prevent motion sickness. He was asked to get into the PIU. A pulse oximeter was attached to his finger and placed inside the PIU so that it could be read from the outside. A thermohydrometer was also placed inside the unit. The patient was given a squeeze-bottle of water, and the unit was sealed and inflated.
When leaving the pre-isolation room, the physician and the PIU were sprayed with a sodium hypochloride solution before the first layer of personal protective equipment was removed. At the exit, the entire medical crew removed a layer of personal protective equipment after being sprayed with sodium hypochloride solution. The team returned to the airport for the flight back to Taiwan. No other personnel or family member was allowed to accompany the patient on the flight.
The patient remained stable and calm throughout the flight. His oxygen saturation remained 97%–99% with heart rate of 90 to 100 beats per minute. Humidity was maintained at 60% and temperature at 28°C. On arrival, the team proceeded to the isolation ward. The physician accompanied the patient into the isolation room; the patient was released from the PIU and transferred to receiving medical team.
On exiting the isolation room, the empty PIU and the medical team were sprayed with sodium hypochloride. All equipment was sprayed and put into biohazard bags. The medical team then discarded the last layer of impermeable clothing. The PIU was left in biohazard bags for 24 hours before being sprayed with water and air-dried.
After the assignment, the medical crew self-documented their temperature twice daily for 10 days. All staff remained asymptomatic with normal body temperatures during this period. The patient’s temperature remained normal, and results of a polymerase chain reaction of throat swab were negative for SARS-associated coronavirus (SARS-CoV). He was discharged on June 10, 2003.
When the SARS outbreak occurred in Taiwan, many medical and ambulance personnel were exposed to SARS-CoV while transporting or caring for patients with suspected SARS. As SARS was an emerging infectious disease, the mechanism of transmission was still unclear. Although one report by Christopher and Eitzen (2) suggested the value of an aeromedical team to evacuate patients with suspected lethal, infectious diseases, limited evidence supported a safer transportation that would possibly reduce transmission of SARS to persons taking part in the mission.
When the SARS epidemic spread to remote islands, aircraft refused to transport patients with a case of suspected SARS unless certain precautions were implemented. Smaller aircraft used on domestic routes in Taiwan do not meet the standards set for transporting SARS patients (3,4), which prompted the design of the PIU, an airtight polyvinyl chloride bag with a one-way inlet valve and an exhalation valve. The valves were modified by incorporating HEPA filters on both sides of the valves and then connecting a ventilator with an oxygen source to the inlet valve. The respiratory rate and tidal volume are set, depending on weight and oxygen requirements of the patient. By regulating the exhalation valve, the minimum pressure inside the bag can be manipulated to keep it from collapsing, since the bag has no internal or external frame.
The PIU has some limitations. No physical contact with the patient is possible after the PIU is sealed and inflated. Very strict criteria on the suitability of a patient to be transported are followed. Any patient who is unconscious, uncooperative, or whose condition may deteriorate is not transportable in this unit. Because of possible discomfort, a maximum total transport time of 2 to 4 hours is suggested. This time frame works well in Taiwan; all locations in the country, including the outer islands, are within a 4-hour limit.
The use of PIU during the SARS crisis had a number of positive effects in Taiwan. It enabled the safe transport of SARS patients between hospitals by air and road and decreased the risk of cross-infecting transport personnel. The anxiety of transport personnel was decreased, as was the fear felt by the population of the outer islands. In addition, the credibility of the local health authorities was improved among the general population in Taiwan.
Dr. Tsai is the director of the NACC, associate professor at Taipei Medical University, and chairman of the Department of Emergency and Critical Care Medicine at Wang Fang Hospital, Taipei. He is a specialist in critical care medicine, neurologic surgery, and aviation medicine. He participates in academic and research work on injury and disease prevention and control.
We thank Charles van Reenen, Philippe Barrault, Roger Farrow, Pascal Rey Herme, and International SOS for developing the PIU and their full support during the transport of SARS patients in Taiwan.
The study was supported by a grant from the Department of Health, Taiwan (DOH 135860) and a grant from National Health Research Institute, Taiwan (NHRI-EX 93-9106PN).
- Center for Disease Control, Department of Health, Taiwan. Prevention and control of SARS in Taiwan (2nd edition). Sindian (Taiwan): Yu Hwa; 2003.
- Christopher GW, Eitzen EM. Air evacuation under high-level biosafety containment: the aeromedical isolation team. Emerg Infect Dis. 1999;5:241–6.
- Centers for Disease Control and Prevention. Interim guidance: air medical transport for severe acute respiratory syndromes (SARS) patients [monograph on the Internet]. 2003 May 8 [cited 2003 Jun 28]. Available from: http://www.cdc.gov/ncidod/sars/airtransport-sarspatients.htm
- Interim Domestic Infection Control Precautions for aerosol-generating procedures on patients with severe acute respiratory syndromes (SARS). Centers for Disease Control and Prevention. 2003 May 20 [cited 2003 Jun 28]. Available from http://www.cdc.gov/ncidod/sars/aerosolinfectioncontrol.htm
Please use the form below to submit correspondence to the authors or contact them at the following address:
Wen-Ta Chiu, Institute of Injury Prevention and Control at Taipei Medical University and Wan Fan Hospital, 250 Wu-Shin Street, Taipei, Taiwan, 110; fax: 886-2-27390387
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: January 27, 2011
- Page last updated: January 27, 2011
- Page last reviewed: January 27, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)